Sagiment plans to use the potential $66 million to further development of denifanstat, or TVB-2640, an oral, once-daily pill that is being evaluated in a phase 2b trial for patients with non ...

Niagen Bioscience, Inc., the global authority on NAD+ with a focus on the science of healthy aging, today announces that senior management will participate at the Roth 15 th Annual London ...

Sagimet (SGMT) shares rallied 23% in the wake of its Q4 earnings report and several corporate updates, including the extension of its cash runway through 2025. Read more here.

About PL BioScience: Located in Aachen in Germany, PL BioScience GmbH is a life science company specializing in the production and development of Human Platelet Lysate (HPL), ...